Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients
Recruiting
Phase 1
Phase 2
Interventional Study
Long COVID
Post-Acute COVID-19 Syndrome
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 76 (estimated)
- Sponsor
- Changhai Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the effectiveness and safety of mesenchymal stem cell therapy in long-COVID patients. The main questions it aims to answer include:
* whether umbilical cord mesenchymal stem cell therapy does benefit long-COVID patients
* whether umbilical cord mesenchymal stem cell therapy is safe for long-COVID patients.
Participants' demographics, chief complaint…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Meeting the diagnostic criteria for Long COVID according to WHO.
* Main symptoms assessed based on CTCAE 5.0.
* Symptoms evaluated for exclusion reasons of other diseases by relevant specialists.
* No recent plans for pregnancy (negative pregnancy test within 72 hours for wome…
Contacts